IL138812A0 - Treatment of cardiac hypertrophy - Google Patents

Treatment of cardiac hypertrophy

Info

Publication number
IL138812A0
IL138812A0 IL13881299A IL13881299A IL138812A0 IL 138812 A0 IL138812 A0 IL 138812A0 IL 13881299 A IL13881299 A IL 13881299A IL 13881299 A IL13881299 A IL 13881299A IL 138812 A0 IL138812 A0 IL 138812A0
Authority
IL
Israel
Prior art keywords
treatment
cardiac hypertrophy
hypertrophy
cardiac
Prior art date
Application number
IL13881299A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL138812A0 publication Critical patent/IL138812A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
IL13881299A 1998-04-02 1999-03-19 Treatment of cardiac hypertrophy IL138812A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8044898P 1998-04-02 1998-04-02
PCT/US1999/006032 WO1999051260A2 (en) 1998-04-02 1999-03-19 Treatment of cardiac hypertrophy

Publications (1)

Publication Number Publication Date
IL138812A0 true IL138812A0 (en) 2001-10-31

Family

ID=22157456

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13881299A IL138812A0 (en) 1998-04-02 1999-03-19 Treatment of cardiac hypertrophy

Country Status (18)

Country Link
US (2) US6187304B1 (xx)
EP (2) EP1067958B1 (xx)
JP (2) JP5030329B2 (xx)
CN (1) CN1201814C (xx)
AR (1) AR018174A1 (xx)
AT (2) ATE410181T1 (xx)
AU (1) AU757910B2 (xx)
BR (1) BR9909422A (xx)
CA (1) CA2325442C (xx)
DE (2) DE69932235T2 (xx)
DK (2) DK1067958T3 (xx)
ES (2) ES2314786T3 (xx)
HK (2) HK1036019A1 (xx)
IL (1) IL138812A0 (xx)
NZ (1) NZ506854A (xx)
TW (1) TWI243682B (xx)
WO (1) WO1999051260A2 (xx)
ZA (1) ZA200004854B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192659A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ES2314786T3 (es) * 1998-04-02 2009-03-16 Genentech, Inc. Uso de interferon gamma para el tratamiento de la hipertrofia cardiaca.
WO2001003720A2 (en) * 1999-07-12 2001-01-18 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
US7838225B2 (en) * 1999-10-29 2010-11-23 Hologic, Inc. Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
US8110218B2 (en) * 2000-11-30 2012-02-07 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein-lipid complexes
US7625584B2 (en) * 2000-11-30 2009-12-01 The Research Foundation Of State University Of New York Method of complexing a protein by the use of a dispersed system and proteins thereof
WO2002089828A2 (en) * 2001-05-04 2002-11-14 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
EP1450849A4 (en) * 2001-11-06 2005-06-29 Applied Research Systems METHOD FOR TREATING ENDOMETREOSE
EP2311489A3 (en) * 2002-02-14 2013-08-21 Chugai Seiyaku Kabushiki Kaisha Formulation of antibody-containing solutions comprising a sugar as a stabilizer
KR101092048B1 (ko) * 2002-08-29 2011-12-12 산텐 세이야꾸 가부시키가이샤 Ｒｈｏ 키나아제 억제제 및 프로스타글란딘류를 포함하는녹내장 치료제
JP4314433B2 (ja) * 2002-11-18 2009-08-19 参天製薬株式会社 Ｒｈｏキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
EP3029061B1 (en) * 2008-06-18 2017-09-13 The Texas A&M University System Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5582824A (en) 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US5096705A (en) 1981-10-19 1992-03-17 Genentech, Inc. Human immune interferon
US4929544A (en) 1982-04-23 1990-05-29 Sri International Reagents, methods, and test kit for diagnosing/monitoring cancer in humans
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4944941A (en) 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5151265A (en) 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
SE462364B (sv) 1988-09-30 1990-06-18 Goeran Hansson Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos
EP0502997B1 (en) 1989-12-01 1995-05-03 Children's Medical Center Corporation Use of gamma-interferon for the manufacture of a medicament in the treatment of steroid dependent asthma
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5573762A (en) 1995-04-24 1996-11-12 Genentech, Inc. Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
DE69636112T2 (de) * 1995-08-30 2006-12-14 Toray Industries, Inc. Verfahren zum testen von myocarditis und cardiomyopathie
ES2314786T3 (es) * 1998-04-02 2009-03-16 Genentech, Inc. Uso de interferon gamma para el tratamiento de la hipertrofia cardiaca.

Also Published As

Publication number Publication date
WO1999051260A3 (en) 1999-12-09
JP2009256375A (ja) 2009-11-05
AR018174A1 (es) 2001-10-31
DE69932235D1 (de) 2006-08-17
US6989364B1 (en) 2006-01-24
JP2002510645A (ja) 2002-04-09
NZ506854A (en) 2003-07-25
HK1036019A1 (en) 2001-12-21
CN1300221A (zh) 2001-06-20
AU757910B2 (en) 2003-03-13
US6187304B1 (en) 2001-02-13
DE69932235T2 (de) 2007-06-14
ES2314786T3 (es) 2009-03-16
EP1067958B1 (en) 2006-07-05
EP1702623B1 (en) 2008-10-08
TWI243682B (en) 2005-11-21
JP5030329B2 (ja) 2012-09-19
EP1702623A3 (en) 2007-01-10
ES2267258T3 (es) 2007-03-01
HK1099197A1 (en) 2007-08-10
CA2325442A1 (en) 1999-10-14
CN1201814C (zh) 2005-05-18
ATE332144T1 (de) 2006-07-15
DK1702623T3 (da) 2009-01-19
EP1702623A2 (en) 2006-09-20
ZA200004854B (en) 2001-09-26
AU3102499A (en) 1999-10-25
DK1067958T3 (da) 2006-11-06
WO1999051260A2 (en) 1999-10-14
DE69939723D1 (de) 2008-11-20
EP1067958A2 (en) 2001-01-17
CA2325442C (en) 2011-10-11
ATE410181T1 (de) 2008-10-15
BR9909422A (pt) 2001-09-11

Similar Documents

Publication Publication Date Title
GB2335153B (en) Treatment of water
GB9824436D0 (en) Methods of treatment
HK1099197A1 (en) Use of interferon gamma for the treatment of cardiac hypertrophy
AP9901683A0 (en) Treatment of water
AU8451298A (en) Treatment of fabrics
GB9812941D0 (en) Method of treatment
GB2343629B (en) Treatment of cellulite
HK1041202A1 (en) Novel method of treatment
GB9822681D0 (en) Method of treatment
GB9822458D0 (en) Methods of treatment
GB9824208D0 (en) Methods of treatment
GB9800707D0 (en) Methods of treatment
GB9824791D0 (en) Novel methods of treatment
EG24158A (en) Novel method of treatment
GB9701448D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
GB9917181D0 (en) Methods of treatment
GB9818295D0 (en) Treatment of alopecia
GB9818776D0 (en) Method of treatment
GB9822459D0 (en) Method of treatment
GB9811961D0 (en) Method of treatment
GB9808479D0 (en) Method of treatment
GB9824790D0 (en) Novel method of treatment
GB9824789D0 (en) Novel method of treatment
GB9824871D0 (en) Novel method of treatment

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees